Publications by authors named "Anthony W Defusco"

Claim this Profile
P
Preclinical evaluation of the maximum tolerated dose and toxicokinetics of enteric-coated lantibiotic OG253 capsules.
N V Rajeshkumar, Johan A Kers, Scott Moncrief, Anthony W Defusco, Jae H Park

Toxicol Appl Pharmacol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological, Toxicological, and Dose Range Assessment of OG716, a Novel Lantibiotic for the Treatment of -Associated Infection.
Mark E Pulse, William J Weiss, Johan A Kers, Anthony W DeFusco, Jae H Park

Antimicrob Agents Chemother· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blueprints for the rational design of therapeutic mutacin 1140 variants.
Johan A Kers, R Eryl Sharp, Sheela Muley, Melissa Mayo, Jeffrey Colbeck, Anthony W DeFusco

Chem Biol Drug Des· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OG716: Designing a fit-for-purpose lantibiotic for the treatment of Clostridium difficile infections.
Johan A Kers, Anthony W DeFusco, Jae H Park, Jin Xu, Mark E Pulse

PLoS One· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutacin 1140 Lantibiotic Variants Are Efficacious Against Infection.
Johan A Kers, Robert E Sharp, Anthony W Defusco, Jae H Park, Jin Xu

Front Microbiol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis